CERo Therapeutics Holdings, Inc.
CERO
$9.46
$0.232.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.11M | 671.90K | -4.23M | -2.45M | -2.30M |
| Total Depreciation and Amortization | 269.50K | 284.60K | 297.30K | 293.30K | 288.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 461.20K | -3.74M | 244.40K | -1.96M | -2.16M |
| Change in Net Operating Assets | -70.40K | 1.24M | 927.70K | 576.40K | -905.40K |
| Cash from Operations | -4.45M | -1.54M | -2.76M | -3.54M | -5.08M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 13.70K | 0.00 | 0.00 | 408.10K |
| Total Debt Repaid | -- | -102.30K | -150.90K | -149.30K | -19.70K |
| Issuance of Common Stock | 6.72M | -- | 2.57M | 2.72M | 6.77M |
| Repurchase of Common Stock | -- | -500.80K | -- | -- | -- |
| Issuance of Preferred Stock | -395.00K | -- | 2.73M | 2.00K | -- |
| Repurchase of Preferred Stock | -- | -45.90K | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 2.12M | -2.66M | 13.70K | -- |
| Cash from Financing | 6.32M | 1.49M | 2.49M | 2.59M | 7.16M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.88M | -53.10K | -266.80K | -946.10K | 2.08M |